𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer

✍ Scribed by Savitri Krishnamurthy; Massimo Cristofanilli; Balraj Singh; James Reuben; Hui Gao; Evan N. Cohen; Eleni Andreopoulou; Carolyn S. Hall; Ashutosh Lodhi; Summer Jackson; Anthony Lucci


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
186 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Outcome prediction by molecular detectio
✍ Horibe, Keizo ;Fukuda, Minoru ;Miyajima, Yuji ;Matsumoto, Kimikazu ;Kondo, Masar πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 2 views

Background. We have determined whether sequential molecular detection of minimal residual disease (MRD) in bone marrow (BM) could predict the outcome of patients with advanced neuroblastoma (NB). Procedure. Bone marrow samples from 19 patients over 12 months of age with stage 4 neuroblastoma were se

Comparison of the clinical significance
✍ Gro Wiedswang; Elin Borgen; Cecilie Schirmer; Rolf KΓ₯resen; Gunnar Kvalheim; Jah πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 385 KB πŸ‘ 1 views

## Abstract Immunocytochemical (ICC) detection of disseminated tumor cells (DTC) in bone marrow (BM) in early breast cancer is an independent prognostic factor. The significance of circulating tumor cells (CTC) in peripheral blood (PB) needs further exploration and comparison to DTC detection. PB a

Detection of tumor-specific DNA in blood
✍ Heidi Schwarzenbach; Felix K.-H. Chun; Imke Lange; Sebastian Carpenter; Miriam G πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 605 KB

## Abstract Tumor tissues, blood plasma and bone marrow (BM) aspirates of 57 prostate cancer patients (PCa) without clinical signs of overt metastases were assessed for LOH (loss of heterozygosity) by a PCR‐based fluorescence microsatellite analysis, using a panel of 15 markers. Additionally, micro